학술논문
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML
Document Type
Article
Author
Source
In: Blood Cancer Journal . (Blood Cancer Journal, June 2021, 11(6))
Subject
Language
English
ISSN
20445385